122 related articles for article (PubMed ID: 8820456)
1. Topotecan demonstrates significant activity in small-cell lung cancer.
Oncology (Williston Park); 1996 Mar; 10(3):422-3. PubMed ID: 8820456
[No Abstract] [Full Text] [Related]
2. Topotecan demonstrates significant activity in recurrent small-cell lung cancer.
Oncology (Williston Park); 1996 Jan; 10(1):111. PubMed ID: 8924362
[No Abstract] [Full Text] [Related]
3. Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase II study in patients with refractory and sensitive disease. The European Organization for Research and Treatment of Cancer Early Clinical Studies Group and New Drug Development Office, and the Lung Cancer Cooperative Group.
Ardizzoni A; Hansen H; Dombernowsky P; Gamucci T; Kaplan S; Postmus P; Giaccone G; Schaefer B; Wanders J; Verweij J
J Clin Oncol; 1997 May; 15(5):2090-6. PubMed ID: 9164222
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of topotecan in the treatment of advanced ovarian carcinoma.
ten Bokkel Huinink W; Carmichael J; Armstrong D; Gordon A; Malfetano J
Semin Oncol; 1997 Feb; 24(1 Suppl 5):S5-19-S5-25. PubMed ID: 9122738
[TBL] [Abstract][Full Text] [Related]
5. [DNA topoisomerase inhibitor].
Sugiura T; Ariyoshi Y
Gan To Kagaku Ryoho; 1992 Nov; 19(13):2140-5. PubMed ID: 1332623
[TBL] [Abstract][Full Text] [Related]
6. Clinical studies of topotecan.
Broom C
Ann N Y Acad Sci; 1996 Dec; 803():264-71. PubMed ID: 8993520
[No Abstract] [Full Text] [Related]
7. RFS2000 (9-nitrocamptothecin) in advanced small cell lung cancer, a phase II study of the EORTC New Drug Development Group.
Punt CJ; de Jonge MJ; Monfardini S; Daugaard G; Fiedler W; Baron B; Lacombe D; Fumoleau P;
Eur J Cancer; 2004 Jun; 40(9):1332-4. PubMed ID: 15177492
[TBL] [Abstract][Full Text] [Related]
8. [Irinotekan in spread small cell lung cancer. More studies are required to change the practice].
Sörenson S
Lakartidningen; 2002 May; 99(21):2409. PubMed ID: 12090170
[No Abstract] [Full Text] [Related]
9. Topotecan in small cell lung cancer.
Schiller JH
Semin Oncol; 1997 Dec; 24(6 Suppl 20):S20-27-S20-33. PubMed ID: 9425958
[TBL] [Abstract][Full Text] [Related]
10. Evolving role of topotecan in treating small-cell lung cancer.
Reddy K
Clin Lung Cancer; 2004 Mar; 5(5):270-2. PubMed ID: 15086965
[No Abstract] [Full Text] [Related]
11. Topotecan for the treatment of small-cell lung cancer.
Nicum SJ; O'Brien ME
Expert Rev Anticancer Ther; 2007 Jun; 7(6):795-801. PubMed ID: 17555389
[TBL] [Abstract][Full Text] [Related]
12. Topotecan in small cell lung cancer: first or second line?
Campling B
Cancer Biol Ther; 2004 Jan; 3(1):94-5. PubMed ID: 14739785
[No Abstract] [Full Text] [Related]
13. New chemotherapeutic agents in non-small-cell lung cancer.
Feigal EG; Christian M; Cheson B; Grever M; Friedman MA
Semin Oncol; 1993 Apr; 20(2):185-201. PubMed ID: 7683142
[No Abstract] [Full Text] [Related]
14. Hematologic safety and tolerability of topotecan in recurrent ovarian cancer and small cell lung cancer: an integrated analysis.
Armstrong DK; Spriggs D; Levin J; Poulin R; Lane S
Oncologist; 2005 Oct; 10(9):686-94. PubMed ID: 16249347
[TBL] [Abstract][Full Text] [Related]
15. Topotecan hydrochloride for metastatic ovarian cancer.
Med Lett Drugs Ther; 1996 Oct; 38(986):96-7. PubMed ID: 8906133
[No Abstract] [Full Text] [Related]
16. Foreword--new directions for topotecan in lung cancer treatment.
Stewart DJ
Oncologist; 2004; 9 Suppl 6():1-3. PubMed ID: 15616144
[No Abstract] [Full Text] [Related]
17. Treatment-related fatal sepsis from topotecan/cisplatin and topotecan/paclitaxel.
Miller AA; Lilenbaum RC; Lynch TJ; Rosner GL; Ratain MJ; Green MR; Schilsky RL
J Clin Oncol; 1996 Jun; 14(6):1964-5. PubMed ID: 8656268
[No Abstract] [Full Text] [Related]
18. New options for the treatment of advanced ovarian cancer.
Dunton CJ
Semin Oncol; 1997 Feb; 24(1 Suppl 5):S5-2-S5-11. PubMed ID: 9122739
[TBL] [Abstract][Full Text] [Related]
19. [Topotecan--a new principle of effectiveness in oncology. 4th Salzburg Symposium on Quality of Life. 15-17 December 1995].
Geburtshilfe Frauenheilkd; 1996 Jun; 56(6 Suppl):1-6. PubMed ID: 9022377
[No Abstract] [Full Text] [Related]
20. Diffuse alveolar damage after a single dose of topotecan in a patient with pulmonary fibrosis and small cell lung cancer.
Maitland ML; Wilcox R; Hogarth DK; Desai AA; Caligiuri P; Abrahams C; Salgia R
Lung Cancer; 2006 Nov; 54(2):243-5. PubMed ID: 16949700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
